Lodotra
Links shared publicly online about this topic
Phase 3 study of Lodotra for the treatment of rheumatoid arthritis (RA) - ONA
oncologynurseadvisor.com — “Horizon Pharma announced that data from its Phase 3 study of Lodotra showed a statistically significant improvement in American College of Rheumatology (ACR) response criteria in patients with rheumatoid arthritis (RA).” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 17, 2010 at 6:11 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 study of Lodotra for the treatment of rheumatoid arthritis (RA) http://goo.gl/fb/HWfpl
Phase 3 study of Lodotra for the treatment of rheumatoid arthritis (RA) - MPR
empr.com — “Horizon Pharma announced that data from its Phase 3 study of Lodotra showed a statistically significant improvement in American College of Rheumatology (ACR) response criteria in patients with rheumatoid arthritis (RA).” View full resource at empr.com
Most Recently Shared on June 17, 2010 at 3:09 pm By:
MPR News: Phase 3 study of Lodotra for the treatment of rheumatoid arthritis (RA): Horizon Pharma announced that d... http://bit.ly/cNuEzq
Lodotra (Modified-Release Prednisone) Significantly Reduces Morning Stiffness In Rheumatoid Arthritis
medicalnewstoday.com — “Rome, 18 June 2010: Lodotra - a unique modified-release formulation designed to be taken before bed and release low-dose prednisone in the early hours when inflammatory cytokines peak - achieves c” View full resource at medicalnewstoday.com
Most Recently Shared on June 21, 2010 at 1:07 pm By:
Lodotra (Modified-Release Prednisone) Significantly Reduces Morning Stiffness In Rheumatoid Arthritis http://mnt.to/3F7N #healthnews
Horizon Pharma, Inc. Presents Results Of Phase 3 Studies Of LODOTRA(R) Demonstrating Statistically Significant Improvement In Response In Arthritis
medicalnewstoday.com — “Horizon Pharma, Inc., announced that data from the Phase 3 U.S. registration study of LODOTRA®, a circadian cytokine modulator and novel modified-release, low-dose prednisone tablet, showed a” View full resource at medicalnewstoday.com
Most Recently Shared on June 19, 2010 at 1:04 pm By:
MNT Med Conferences Health News
Horizon Pharma, Inc. Presents Results Of Phase 3 Studies Of LODOTRA(R) Demonstrating Statistically Significant Improve... http://mnt.to/3F6D
Nitec Pharma Reports Positive And Highly Significant Phase III Results From Capra-2 Study Of Lodotra(TM) In RA
medicalnewstoday.com — “Nitec pharma ag (nitec or nitec pharma), a switzerland-based specialty pharma company focused on the development and commercialization of medicines to treat chronic inflammation and pain-relat” View full resource at medicalnewstoday.com
Most Recently Shared on September 3, 2009 at 1:50 pm By:
MNT Arthritis News Health News
Nitec Pharma Reports Positive And Highly Significant Phase III Results From Capra-2 Study Of Lodotra(TM) In RA: .. http://bit.ly/auF37
Horizon Pharma, Inc. Presents Results of Phase 3 Studies of Lodotra Demonstrating Statistically Significant Improvement in Response in Rheumatoid Arthritis Patients - Drugs.com MedNews
drugs.com — “- LODOTRA Demonstrates Sustained Efficacy and Safety in Rheumatoid Arthritis Patients for up to 12-months - Horizon Pharma, Inc., announced today that data from” View full resource at drugs.com
Most Recently Shared on June 16, 2010 at 8:45 pm By:
Horizon Pharma, Inc. Presents Results of Phase 3 Studies of Lodotra Demonstrating Statistically Significant Improv... http://bit.ly/d4diCy
Horizon Pharma, Inc. Announces Results of Phase 3 Study of Lodotra Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis - Drugs.com MedNews
drugs.com — “- Results published in July Issue of Annals of Rheumatic Diseases - Horizon Pharma, Inc. announced today the results from the extended open label portion of The” View full resource at drugs.com
Most Recently Shared on July 24, 2010 at 12:44 pm By:
Horizon Pharma, Inc. Announces Results of Phase 3 Study of Lodotra Demonstrate 12-Month Sustained Efficacy and Saf... http://bit.ly/cQkH1c
YouTube - Modified-Release Prednisone for RA
youtube.com — “Dr. Frank Buttgereit of Berlin discusses Lodotra, a modified-release formulation of prednisone designed to reduce morning joint stiffness in rheumatoid arthr...” View full resource at youtube.com
Most Recently Shared on September 3, 2010 at 6:57 pm By:
Bob Finn - Medical News Net Health News
Modified-Release Prednisone for #Rheumatoid #Arthritis . Video w Dr. Frank Buttgereit by Bruce Jancin for MNN. http://youtu.be/pNrTexbVeyM
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
Advertisement
